RKRachel M. Kruer

Rachel M. Kruer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rachel M. Kruer has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Decision fatigue in hospital medicine: A retrospective exploratory evaluation

    by Rachel M. Kruer, LaKeisha Boyd, Lauren Czosnowski, Sarah Jones, Kelsey Perry, Thomas J. Streepey, Areeba Kara

    Background: “Decision fatigue” (DF) is the deterioration in decision‐making ability stemming from repeated decision making. Objective: Explore DF over the clinical workblock and across hospitalist and work characteristics. Methods: Patients seen by hospitalists at two hospitals in January and February 2022 were retrospectively evaluated for events that may reflect DF. Events were selected through multistakeholder discussion (prescription of pharmacologically antagonistic medications, occurrence of hypoglycemia, and potential overuse of blood transfusions, imaging, and penicillin alternatives). For each date, schedules determined the number of days each hospitalist had been on service and charges submitted assessed census and physician familiarity with their team. Charges and ordering data guided event attribution. The primary predictor was the number of days on service, and the outcome was event occurrence. Secondary predictors included hospitalist gender, weekend versus weekday, census, site, and degree of familiarity. Results: During the study, 43 hospitalists worked 1306 days over 204 working blocks, providing care to 2081 patients over 3122 encounters. Median daily census was 13, median number of consecutive days worked was seven. DF events were not associated with the primary or secondary predictors except census. In the multivariable model, each one unit increase in the number of patients was associated with event occurrence (odds ratio [OR]: 1.107, 95% confidence interval [CI]: 1.022–1.198, p = .01). The odds of an event were 1.58 times greater at workloads above the median of 13 patients, compared with workloads ≤13. ( p = .002). Conclusion: DF was not detected with an increasing number of days on clinical service. The findings highlight how workloads may threaten care quality.


  • Open Access

    Decision fatigue in hospital settings: A scoping review

    by Kelsey Perry, Sarah Jones, Julia C. Stumpff, Rachel Kruer, Lauren Czosnowski, Deanne Kashiwagi, Areeba Kara

    Background: “Decision Fatigue” (DF) describes the impaired ability to make decisions because of repeated acts of decision‐making.Objectives: We conducted a scoping review to describe DF in inpatient settings.Methods: To be included, studies should have explored a clinical decision, included a mechanism to account for the order of decision making, and be published in English in or after the year 2000. Six databases were searched. Retrieved citations were screened and retained studies were reviewed against the inclusion criteria. References of included studies were manually searched, and forward citation searches were conducted to capture relevant sources.Results: The search retrieved 12,781 citations, of which 41 were retained following screening. Following review, 16 studies met the inclusion criteria. Half were conference abstracts and none examined hospitalists. Emergency medicine and intensive care settings were the most frequently studied clinical environments (n = 13, 81%). All studies were observational. The most frequently examined decisions were about resource utilization (n = 8, 50%), however only half of these examined downstream clinical outcomes. Decision quality against prespecified standards was examined in four (25%) studies. Work environment and patient attributes were often described but not consistently accounted for in analyses. Clinician attributes were described in four (25%) investigations. Findings were inconsistent: both supporting and refuting DF's role in the outcome studied.Conclusions: The role of clinician, patient, and work environment attributes in mediating DF is understudied. Similarly, the context surrounding the decision under study require further explication and when assessing resource use and decision quality, adjudication should be made against prespecified standards.


  • Expansion of around the clock critical care and emergency medicine clinical pharmacy services at a large urban academic medical center

    by Rachel M. Kruer, Quinn Czosnowski, Emily M. Miller, Eve Anderson, Haley Peters, Alyson T. Basting, Christian Hauser, Briana Negaard, Joseph Stoldt, Dalena Vo, et al.


  • Open Access

    Corticosteroid Use in Severely Hypoxemic COVID-19 Patients: An Observational Cohort Analysis of Dosing Patterns and Outcomes in the Early Phase of the Pandemic

    by Omar Rahman, Russell A. Trigonis, Mitchell K. Craft, Rachel M. Kruer, Emily M. Miller, Colin L. Terry, Sarah A. Persaud, Rajat Kapoor

    INTRODUCTION: Hypoxemia in Severe Acute Respiratory Syndrome due to Novel Coronavirus of 2019 (SARS-CoV-2) is mediated by severe inflammation that may be mitigated by corticosteroids. We evaluated pattern and effects of corticosteroid use in these patients during an early surge of the pandemic. METHODS: Observational study of 136 SARS-CoV-2 patients admitted to the Intensive care Unit between March 1 and April 27, 2020 at a tertiary care hospital in Indianapolis, USA. Statistical comparison between cohorts and dosing pattern analysis was done. Outcome measures included number of patients requiring intubation, duration of mechanical ventilation, length of ICU stay and inpatient mortality. RESULTS: Of 136 patients, 72 (53%) received corticosteroids. Groups demographics: Age (60.5 vs. 65; p .083), sex (47% male vs. 39% female; p .338) and comorbidities were similar. Corticosteroid group had increased severity of illness: PaO2/FiO2 (113 vs. 130; p .014) and SOFA (8 vs. 5.5; p < .001). Overall mortality (21% vs. 30%; p .234) or proportion of patients intubated (78 vs. 64%; p .078) was similar. Mortality was similar among mechanically ventilated (27% vs. 15%; p .151) however there were no deaths among patients who were not mechanically ventilated and received corticosteroids (0% vs. 57%; p <.001). Early administration (within 48 hours) showed decrease in proportion of intubation (66% vs. 87 vs. 100%; p .045), ICU days (6 vs., 16 vs. 18; p <.001), and ventilator days (3 vs. 12 & 14; p <.001). 45% received methylprednisolone. CONCLUSION: Corticosteroids were used more frequently in SARS CoV-2 patients with higher severity of illness. Early administration of corticosteroids improved survival in non-mechanically ventilated patients; decreased ICU stay and may have prevented intubation.


  • Open Access

    Use and Effectiveness of Peri-Operative Cefotetan versus Cefazolin Plus Metronidazole for Prevention of Surgical Site Infection in Abdominal Surgery Patients

    by Eleanor Danan, Janessa Smith, Rachel M. Kruer, Edina Avdic, Pamela Lipsett, Melanie S. Curless, Andrew S. Jarrell

    Background: Current practice guidelines for antimicrobial prophylaxis in surgery recommend a cephamycin or cefazolin plus metronidazole for various abdominal surgeries. In February 2016, cephamycin drug shortages resulted in a change in The Johns Hopkins Hospital's (JHH) recommendation for peri-operative antibiotic prophylaxis in abdominal surgeries from cefotetan to cefazolin plus metronidazole. The primary objective of this study was to quantify the percentage of abdominal surgeries adherent to JHH peri-operative antibiotic prophylaxis guidelines. A sub-group analysis investigated whether prophylaxis with cefazolin plus metronidazole was associated with a lower rate of surgical site infections (SSIs) versus cefotetan. Patients and Methods: This retrospective cohort study included adult inpatients who underwent an abdominal surgery at JHH in September 2015 (Study Period I: cefotetan) or February to March 2016 (Study Period II: cefazolin plus metronidazole). Results: Two hundred abdominal surgery cases were included in the primary analysis. A subset of 156 surgical cases were included in the sub-group analysis. The overall adherence rate to JHH guidelines was 75% in Study Period I versus 17% in Study Period II (p < 0.001). The largest difference in adherence was attributed to pre-operative administration time (87% vs. 23%, p < 0.001), primarily because of the longer infusion time required for metronidazole. Surgical site infections occurred in 14% (12/83) of surgeries with cefotetan versus 8.2% (6/73) with cefazolin plus metronidazole for prophylaxis (p = 0.19). Conclusions: Adherence to an institution-specific peri-operative antibiotic prophylaxis guideline for abdominal surgeries was limited primarily by the longer infusion time required for pre-operative metronidazole. A higher percentage of SSIs occurred among abdominal surgeries with cefotetan versus cefazolin plus metronidazole for prophylaxis.